CSIMarket


Ascendis Pharma A  (ASND)
Other Ticker:  
 


 

Ascendis Pharma A

ASND's Financial Statements and Analysis



Ascendis Pharma A reported in the forth quarter of 2022 net loss per share of $-11.65 compare to earnings per share of $0.00 in the same quarter a year ago a decrease compare to $0.00 realized in previous quarter.


forth quarter of 2022
Earnings Per Share Revenues
$ -11.65 $  57 Mill
$-11.65     $+49M     +557.93 %



Ascendis Pharma A's Revenue rose by 557.93 % in forth quarter of 2022 (Dec 31 2022) year on year, to $57 million and advanced by sequentially.


Ascendis Pharma A is

More on ASND's Income Statement



Ascendis Pharma A in the forth quarter of 2022 recorded net loss of $-653.177 million, an increase from net loss of $-429.606 million in IV. Quarter a year ago.

Sequentially company realized a net loss, compared to net income of $0.000 million in the previous quarter.

More on ASND's Growth

Ascendis Pharma A Inventories
ASND's Cash flow In the forth quarter of 2022 company's net cash flow was $500 million, capital expenditures grew by -26.54848-38.88%, to $-16 millions compare to same quarter a year ago

More on ASND's Cash flow Statement


Ascendis Pharma A does not pay out common stock dividend.

In trailing twelve-month period Ascendis Pharma A payed $ -19.78 cash per share, on a free-cash flow basis .

Book value fell by 0.00 % sequentially to $5.26 per share.
Tangible Book value fell to $ 5.26 per share from $ 5.26.

Company repurchased 0.00 million shares or 0.00 % in Dec 31 2022.


More on ASND's Dividends

 Market Capitalization (Millions) 7,157
 Shares Outstanding (Millions) 56
 Total Debt (Millions $) 541
 Revenue (TTM) (Millions $) 57
 Net Income (TTM) (Millions $) -653
 Cash Flow (TTM) (Millions $) 500
 Capital Exp. (TTM) (Millions $) -16
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Ascendis Pharma A does not pay out common stock dividend.

In trailing twelve-month period Ascendis Pharma A had negative $ -19.78 cash flow per share, on a free-cash flow basis .

Book value fell by 0.00 % sequentially to $5.26 per share.
Tangible Book value fell to $ 5.26 per share from $ 5.26.

Company repurchased 0.00 million shares or 0.00 % in Dec 31 2022.


More on ASND's Balance Sheets

 Market Capitalization (Millions) 7,157
 Shares Outstanding (Millions) 56
 Total Debt (Millions $) 541
 Revenue (TTM) (Millions $) 57
 Net Income (TTM) (Millions $) -653
 Cash Flow (TTM) (Millions $) 500
 Capital Exp. (TTM) (Millions $) -16
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Ascendis Pharma A Earnings